Editas Medicine Announces The FDA Has Cleared Initiation Of The EDIT-301 Clinical Trial

Gene editing

Home » Emerging technologies » Gene editing » Page 2

Intellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments

Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research

eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec

FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia Therapeutics

IDT launches Alt-R™ HDR Design Tool and Templates

squirrel

What squirrels can teach us about why, when, and how to use gene drives

Agragene

Agragene Raises $1.2 Million in Seed Round Financing From Ospraie Ag Science

Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA

Cibus Achieves Critical Milestones for Two New Gene-Edited Traits that Increase Productivity for Rice Farmers